Planview and Ozmosi: Bringing AI-Powered Insight to Pharmaceutical Portfolio Decisions

Pharmaceutical organizations are under increasing pressure to make faster, smarter R&D decisions in an environment defined by complexity, uncertainty, and constant change. Making the environment even more vulnerable – and volatile – is the looming “patent cliff” for some of the world’s best-selling drugs, which some analysts predict will trigger up to $350 billion in losses by 2032, according to CNBC.

Lentech Names Mike Majarov Chief Innovation, IT Officer

Lentech has appointed Mike Majarov as chief innovation and information technology officer, a newly created role aimed at strengthening the company’s technology strategy and supporting its growth in the government contracting market. Majarov will overse…

Echeverry Shares Insights About her Career in Architecture

Viviana Echeverry is an enterprise architect and digital transformation leader whose work sits at the intersection of technology strategy, innovation, and business outcomes. Currently serving in a global digital enterprise architecture role at IKEA, sh…

Navigate Software Delivery with Speed

Modern product leadership is not simply about managing features, scheduling releases, or filling dashboards with data – it is a navigation exercise. The roadmap is vast, customer needs evolve quickly, and priorities shift like weather fronts over open water. Even well-staffed engineering teams and mature product processes can find themselves off-course when context is scattered,…

Rethinking Business Processes for the Age of AI

By Vasily Yamaletdinov, Enterprise Architect, Raiffeisen Bank Over recent decades, the concept of a “business process” has been the cornerstone of any organization’s operating model, defining an ordered sequence of interconnected acti…

How to Build a Ranking Model That Drives Better Portfolio Outcomes

The hardest part of portfolio management isn’t generating ideas — it’s choosing which ones truly deserve investment, and in what order. As demand grows and capacity remains constrained, portfolio leaders face constant pressure to make confident, defensible trade-offs. Yet in many organizations, prioritization still relies heavily on influence, urgency, or fragmented data rather than a…